BICO Group Dirección

Dirección controles de criterios 2/4

El CEO de BICO Group's es Maria Forss , nombrado en Nov 2023, tiene una permanencia de menos de un año. compensación anual total es SEK7.43M, compuesta por 6.5% salario y 93.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.057% de las acciones de la empresa, por valor de €159.45K. La antigüedad media del equipo directivo y de la junta directiva es de 1.3 años y 3.7 años, respectivamente.

Información clave

Maria Forss

Chief Executive Officer (CEO)

kr7.4m

Compensación total

Porcentaje del salario del CEO	6.5%
Permanencia del CEO	less than a year
Participación del CEO	0.06%
Permanencia media de la dirección	1.3yrs
Promedio de permanencia en la Junta Directiva	3.7yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Maria Forss en comparación con los beneficios de BICO Group?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	-kr2b
Dec 31 2023	kr7m	kr484k	-kr2b

Compensación vs. Mercado: La compensación total ($USD712.42K) de Maria está en línea con el promedio de empresas de tamaño similar en el mercado German ($USD759.69K).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Maria con los resultados de la empresa.

CEO

Maria Forss (52 yo)

less than a year

Permanencia

kr7,425,520

Compensación

Ms. Maria Forss serves as President & CEO of BICO Group AB (publ) since November 20, 2023. She served as Senior Vice President of Consumables at Vitrolife AB (publ) since January 01, 2022 until August 2023...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Maria Forss	President & CEO	less than a year	kr7.43m	0.057% SEK 158.3k
Jacob Thordenberg	Group Chief Financial Officer	1.4yrs	sin datos	0.026% SEK 72.8k
Marius Balger	Chief Operating Officer	1.3yrs	sin datos	sin datos
Asa Hillsten	Senior VP & Head of Investor Relations	no data	sin datos	sin datos
Lotta Bus	SVP, General Counsel	4.4yrs	sin datos	0.0099% SEK 27.7k
Artur Aira	Head of Corporate Development and M&A	1.3yrs	kr150.00k	0% SEK 0
Catharina Nordlund	Global Head of Human Resources	less than a year	sin datos	sin datos
Itedale Redwan	Chief Scientific Officer - Bioprinting	no data	sin datos	sin datos
Niclas Emanuelsson	Head of Global Operations	4.4yrs	sin datos	sin datos
Holger Eickhoff	Senior VP & Business Area Director - Bioautomation	2.4yrs	sin datos	sin datos
Erica Bell	Senior VP & Chief People Officer	no data	sin datos	sin datos
Nicolas Gabriel-Robez	Chief Security Officer	no data	sin datos	sin datos

1.3yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 49Z no se considera experimentado ( 1.2 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Rolf Classon	Independent Chairman of the Board	2.2yrs	kr650.00k	0.044% SEK 122.5k
Christian Wildmoser	Independent Director	4.5yrs	kr285.00k	0.45% SEK 1.3m
Robert Langer	Member of Scientific Advisory Board	3.6yrs	sin datos	sin datos
Helena Skantorp	Independent Director	4.5yrs	kr350.00k	0.0057% SEK 15.8k
Ulrika Dellby	Independent Deputy Chairwoman	2.2yrs	kr510.00k	0.027% SEK 75.1k
Bengt Sjoholm	Independent Director	8.4yrs	kr285.00k	0.49% SEK 1.4m
Susan Tousi	Independent Director	2.6yrs	kr250.00k	sin datos
Ali Khademhosseini	Member of Scientific Advisory Board	7.3yrs	sin datos	sin datos
Ido Amit	Member of Scientific Advisory Board	3.8yrs	sin datos	sin datos
Alexandra Gatzemeyer	Director	less than a year	sin datos	sin datos

3.7yrs

Permanencia media

69yo

Promedio de edad

Junta con experiencia: La junta directiva de 49Z se considera experimentada (3.7 años de antigüedad promedio).

BICO Group Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

Group Chief Financial Officer recently bought €75k worth of stock

BICO Group AB (publ) Announces Chief Executive Officer Changes

Recent updates

New minor risk - Profitability

No longer forecast to breakeven

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

First quarter 2024 earnings released: kr0.40 loss per share (vs kr1.67 loss in 1Q 2023)

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2024 Results on Feb 19, 2025

BICO Group AB (publ) to Report Q3, 2024 Results on Nov 13, 2024

Full year 2023 earnings released: kr24.05 loss per share (vs kr12.94 loss in FY 2022)

New major risk - Revenue and earnings growth

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

Group Chief Financial Officer recently bought €75k worth of stock

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Mar 15, 2024

Second quarter 2023 earnings released: kr12.73 loss per share (vs kr0.68 profit in 2Q 2022)

BICO Group AB (publ) Announces Chief Executive Officer Changes

Beos Light Industrial Germany 1 Fund, a fund managed by BEOS AG agreed to acquire property on Wagner-Régeny-Straße 15 from BICO Group AB (publ) (OM:BICO) for €21 million.

BICO Group AB (publ) Elects Gerry Mackay to Its Board of Directors

First quarter 2023 earnings released: kr1.67 loss per share (vs kr0.68 loss in 1Q 2022)

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 20, 2024

Full year 2022 earnings released: kr13.00 loss per share (vs kr3.97 loss in FY 2021)

Independent Chairman of the Board recently sold €747k worth of stock

BICO Group AB Appoints Marius Balger as Chief Operating Officer, Effective March 1, 2023

BICO Group AB Announces the Appointment of Jacob Thordenberg as Group CFO

BICO Group AB (publ) to Report Q1, 2023 Results on May 04, 2023

Now 28% undervalued

Third quarter 2022 earnings released

BICO Group AB (publ) to Report Q2, 2023 Results on Jul 20, 2023

BICO Group Announces Appointment of Nomination Committee 2023

Forecast breakeven date moved forward to 2022

Second quarter 2022 earnings released

Forecast breakeven date moved forward to 2022

Now 22% undervalued after recent price drop

First quarter 2022 earnings released: kr0.68 loss per share (vs kr0.90 loss in 1Q 2021)

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 22, 2023

BICO Group Adds Åsa Hillsten as SVP and Head of IR

BICO Group AB (publ) (OM : BICO) acquired Allegro 3D for $11 million.

BICO (publ) Appoints Mikael Engblom as Interim CFO

Now 23% undervalued after recent price drop

High number of new and inexperienced directors

BICO Group AB (Publ) Announces Board Appointments

Co-Founder recently bought €94k worth of stock

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

BICO Reaches Beneficial and Sustainable Solution with Organovo

DISPENDIX, A BICO Company, Announces That the I.DOT HT Non-contact Dispenser and the L.DROP Liquid Handler will be introduced at SLAS 2022

BICO Group AB Announces Statement Regarding Counterclaims in Patent Lawsuit by Organovo Against Cellink

Co-Founder recently bought €1.9m worth of stock

BICO Group AB (publ) (OM:BICO) agreed to acquire Biosero Llc.

Third quarter 2021 earnings released

Insider recently sold €1.1m worth of stock

BICO Group AB (publ) (OM:BICO) acquired all outstanding shares in Advanced BioMatrix, Inc. for $18 million.

CEO & Director recently sold €17m worth of stock

Second quarter 2021 earnings released: kr0.89 loss per share (vs kr0.58 loss in 2Q 2020)

CELLINK Receives Patent for Robotic Systems for Personalized and Automated Aesthetic Medical Procedures

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Discover Echo Inc.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Nanoscribe GmbH for approximately €37 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Nanoscribe GmbH for €34 million.

First quarter 2021 earnings released

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire MatTek Corporation for $68 million.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Ginolis Ltd from Verso Fund II of Verso Capital Oy, Finnvera plc and Innovestor Ventures for €65.7 million.

Cellink AB (publ) to Report Fiscal Year 2021 Results on Mar 16, 2022

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Ginolis Ltd for €70 million.

New 90-day high: €30.00

Cellink AB (publ) Announces Distribution Agreement Including New Products for Single-Cell RNA Sequencing and NGS Library Preparation

Cellink Announces Third Year Extension of Collaboration with A Global Biopharmaceutical Company for Drug Discovery

Cellink and Phasefocus Announces a Partnership to Bring Livecyte High Content Live Cell Imager to a Wider Audience

New 90-day high: €25.25

Cellink AB (publ) Elects Aristotelis Nastos as Member of the Board of Directors

New 90-day high: €21.65

CELLINK and Atelerix Team Up to Enable the Shipping At Room Temperature of Fragile 3D Bioprinted Constructs by the World's Bioprinting Community